LINX

Did you Know?

As many as 10% of GERD patients develop Barrett's esophagus (a pre-cancerous condition of the esophagus)

Clinical Data for LINX

Please click on the links included below to learn more about the results of studies conducted on the LINX® Reflux Management System.

Torax Medical Presentation to FDA Advisory Panel (January 11, 2012)
Annals of Surgery - Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure.
Journal of Gastrointestinal Surgery - Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial.
Journal of Gastrointestinal Endoscopy - Use of a magnetic sphincter for the treatment of GERD: a feasibility study.

CAUTION - Torax's FENIX™ Continence Restoration System is an INVESTIGATIONAL DEVICE, LIMITED BY U.S. FEDERAL LAW TO INVESTIGATIONAL USE. Not available for sale in the United States.

The FENIX™ Continence Restoration System has received European CE Mark approval for treatment of Fecal Incontinence (FI) and is available for sale in Europe.
Torax® Medical, LINX® Reflux Management System and FENIX™ Continence Restoration System are trademarks of Torax®Medical, Inc.
© 2011 Torax® Medical, Inc. All rights reserved.

Your Location:

LINX

Did you Know?

Clinical Data for LINX

CAUTION - Torax's FENIX™ Continence Restoration System is an INVESTIGATIONAL DEVICE, LIMITED BY U.S. FEDERAL LAW TO INVESTIGATIONAL USE. Not available for sale in the United States.